Prime Medicine, Inc. (PRME) Net Margin
- 2025-12-31: Net Margin -5498.69%.
- 2025-09-30: Net Margin -4129.14%.
- 2025-06-30: Net Margin -4716.68%.
- 2025-03-31: Net Margin -3568.78%.
Complete source-backed net margin history.
- Available history
- 2020-12-31 to 2025-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -5498.69% |
| 2025-09-30 | -4129.14% |
| 2025-06-30 | -4716.68% |
| 2025-03-31 | -3568.78% |
| 2024-12-31 | -1936.60% |
| 2024-09-30 | -25128.23% |
| 2024-03-31 | -7742.98% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -4342.44% |
| 2024-12-31 | -6566.61% |
| 2020-12-31 | -65.45% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B |